ClinicalTrials.Veeva

Menu

Telerehabilitation for Multiple Sclerosis (TRHBN)

U

University of Cadiz

Status

Completed

Conditions

Multiple Sclerosis

Treatments

Other: Exercise program
Other: Telerehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06871072
v.1 -11/12/2023

Details and patient eligibility

About

Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system and is a leading cause of disability in young adults. It often produces strength deficits. Exercise has been shown to improve strength, mobility, and quality of life while reducing fatigue. Telerehabilitation offers a convenient, accessible alternative for MS patients. This study explores the use of an AI-powered application for prescribing and monitoring strength exercises, ensuring continuous feedback and adherence. Methods: Randomized clinical trial. Intervention of 3 weekly strength training ses-sions for 20 weeks, patients in the experimental group used the AI application, while patients in the control group followed the conventional method, paper-based exercises with access to videos.

Enrollment

58 patients

Sex

All

Ages

35 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of multiple sclerosis according to the McDonald criteria 2017:
  • Age between 35 and 60 years.
  • Score on the Expanded Disability Status Scale in Multiple Sclerosis by Kurtzke (EDSS) between 2 and 6 points.
  • Patients who do not require assistive devices for home mobility.
  • Patients with no changes in disease-modifying treatment in the last 3 months.
  • Patients who have understood, completed, and signed the informed consent and the study information sheet.

Exclusion criteria

  • Patients who have been regularly performing strength exercises for more than 3 months prior.
  • Moderate/severe cognitive impairment that may interfere with the understanding and/or execution of the study.
  • History of alcohol and/or drug abuse.
  • Presence of a relapse and/or treatment with corticosteroids within the four weeks prior to the start of the study.
  • Patients with severe comorbidities other than MS that may pose a risk for following the exercise guidelines or for their participation in the study for other reasons.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

58 participants in 2 patient groups

Telerehabilitation
Experimental group
Description:
EG performed using an artificial intelli-gence (AI) application called RehBody, which detects body segments, assists in cor-recting the technique and monitoring the exercise, number of sets and repetitions done, and the adherence percentage.
Treatment:
Other: Telerehabilitation
Control group
Active Comparator group
Description:
CG participants followed the exercise program and trained at home with images and videos as support.
Treatment:
Other: Exercise program

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems